As recent FT analysis highlights, corporate America may be waxing lyrical about the promise of artificial intelligence but few boardrooms appear able to describe how the technology is actually changing their businesses for the better. There is, however, one sector where the gains are clear, even if it is less eye-catching to profit-chasing investors: public health. For an industry with intensely high demands on accuracy and efficiency, generative AI could transform healthcare delivery and patient outcomes. In turn, the potential benefits for society, the economy and stretched public budgets are immense.
正如英國《金融時報》最近的分析所強調的那樣，盡管美國企業界對人工智能的前景贊不絕口，但很少有董事會能說明這種科技究竟如何實實在在地改善了他們的業務。不過，有一個領域的收益已相當明確，盡管它對逐利的投資者而言不那么吸睛：公共衛生。對于一個對準確性和效率要求極高的行業，生成式AI有望重塑醫療服務的提供方式并改善患者預后。由此給社會、經濟以及緊張的公共預算方面帶來的潛在收益都將十分可觀。